CLINICAL_TRIALS
trial_result
· 2015-03-06
Clinical Trial Update: Use of NPSP558 in the Treatment of Hypoparathyroidism [Phase 3]
Summary
Phase 3 clinical trial update for NPSP558 in the treatment of hypoparathyroidism has completed with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Hypoparathyroidism | Phase 3 | Status: COMPLETED | Results posted: 2015-03-06